We are live on ! Find out more
FP

Foundry Partners Portfolio holdings

AUM $1.89B
1-Year Est. Return 9.84%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$1.59B
AUM Growth
-$73.3M
Cap. Flow
+$12.5M
Cap. Flow %
0.79%
Top 10 Hldgs %
19.06%
Holding
339
New
37
Increased
202
Reduced
75
Closed
23

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$21.8M
2
BWA icon
BorgWarner
BWA
+$18.9M
3
HIG icon
Hartford Financial Services
HIG
+$18.6M
4
CI icon
Cigna
CI
+$15.3M
5
FOXA icon
Fox Class A
FOXA
+$11.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$25.5M
2
CNC icon
Centene
CNC
+$18.6M
3
QCOM icon
Qualcomm
QCOM
+$13.2M
4
ALLY icon
Ally Financial
ALLY
+$11.4M
5
VZ icon
Verizon
VZ
+$10.8M

Sector Composition

Rank Sector Weight
1 Financials 22.89%
2 Healthcare 13.26%
3 Industrials 11.96%
4 Energy 9.71%
5 Technology 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGEN icon
276
Repligen
RGEN
$7.76B
$305K 0.02%
+1,629
New +$344K
XYL icon
277
Xylem
XYL
$27.8B
$305K 0.02%
3,491
+900
+35% +$81.8K
EPC icon
278
Edgewell Personal Care
EPC
$1.23B
$303K 0.02%
8,090
-960
-11% -$37.4K
FICO icon
279
Fair Isaac
FICO
$28B
$302K 0.02%
+733
New +$333K
OCFC icon
280
OceanFirst Financial
OCFC
$1.69B
$301K 0.02%
16,170
-225
-1% -$4.5K
ON icon
281
ON Semiconductor
ON
$35.1B
$300K 0.02%
+4,806
New +$309K
STE icon
282
Steris
STE
$20.5B
$299K 0.02%
1,799
+464
+35% +$94.4K
CRS icon
283
Carpenter Technology
CRS
$29.9B
$290K 0.02%
9,305
-1,025
-10% -$33.9K
NVDA icon
284
NVIDIA
NVDA
$5.06T
$288K 0.02%
23,750
+10,000
+73% +$158K
PECO icon
285
Phillips Edison & Co
PECO
$5.38B
$286K 0.02%
10,185
-175
-2% -$5.75K
ODFL icon
286
Old Dominion Freight Line
ODFL
$48B
$285K 0.02%
2,294
+590
+35% +$81.6K
SNPS icon
287
Synopsys
SNPS
$71.5B
$280K 0.02%
917
+236
+35% +$79.9K
SBUX icon
288
Starbucks
SBUX
$118B
$278K 0.02%
3,300
+225
+7% +$19.1K
HD icon
289
Home Depot
HD
$324B
$276K 0.02%
+1,000
New +$295K
BMRN icon
290
BioMarin Pharmaceuticals
BMRN
$11.4B
$274K 0.02%
+3,235
New +$288K
DVN icon
291
Devon Energy
DVN
$52.2B
$273K 0.02%
+4,535
New +$282K
IDXX icon
292
Idexx Laboratories
IDXX
$42.5B
$272K 0.02%
835
+215
+35% +$79K
CMG icon
293
Chipotle Mexican Grill
CMG
$41.1B
$270K 0.02%
+9,000
New +$279K
USFD icon
294
US Foods
USFD
$21B
$268K 0.02%
10,129
+2,611
+35% +$81K
CIVI
295
DELISTED
Civitas Resources
CIVI
$262K 0.02%
4,560
+375
+9% +$22.1K
AMZN icon
296
Amazon
AMZN
$2.51T
$260K 0.02%
2,300
– –
CUBI icon
297
Customers Bancorp
CUBI
$2.57B
$252K 0.02%
8,560
+1,735
+25% +$61.4K
FIVE icon
298
Five Below
FIVE
$11.1B
$246K 0.02%
+1,785
New +$234K
HUBS icon
299
HubSpot
HUBS
$9.73B
$242K 0.02%
+896
New +$285K
POR icon
300
Portland General Electric
POR
$6.06B
$235K 0.01%
5,410
-3,060
-36% -$156K
10 11
12
13 14

Similar funds

ST
Sabal Trust St. Petersburg, Florida $1.8B AUM 8.75% 1-Year Est. Return
UH
Unigestion Holding Geneva, Switzerland $1.7B AUM 9.06% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SSB
Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return

Foundry Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Foundry Partners held 339 positions worth $1.59B, down 4.4% from $1.66B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Foundry Partners's Q3 2022 filing shows 37 new, 202 increased, 75 reduced and 23 closed positions. Its largest new stake was Gilead Sciences: 345,955 shares worth $21.3M. The largest sale was Pfizer, an estimated $25.5M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Foundry Partners's largest Q3 2022 buy was Gilead Sciences: 345,955 shares worth $21.3M.
  • Foundry Partners added most to Altria Group in Q3 2022, an estimated $5.64M increase.
  • Foundry Partners's biggest Q3 2022 reduction was Verizon, cutting an estimated $10.8M.
  • Foundry Partners fully exited Pfizer in Q3 2022, selling an estimated $25.5M.
  • Foundry Partners's ten largest holdings make up 19% of its $1.59B portfolio in Q3 2022.
  • Foundry Partners opened 37 new positions and closed 23 in Q3 2022.
  • Foundry Partners's portfolio value fell 4.4% quarter-over-quarter to $1.59B.

Based on Foundry Partners's 13F filing for Q3 2022, filed 21 Oct 2022.